{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:35:07Z","timestamp":1785378907959,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.crad.2020.12.028","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T15:29:35Z","timestamp":1613402975000},"page":"325-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["The imaging of immunotherapy-related hypophysitis and other pituitary lesions in oncology patients"],"prefix":"10.1016","volume":"76","author":[{"given":"A.","family":"Lasocki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Iravani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Galligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2020.12.028_bib1","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1910231","article-title":"Nivolumab plus ipilimumab in advanced non-small-cell lung cancer","volume":"381","author":"Hellmann","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2020.12.028_bib2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma","volume":"378","author":"Motzer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2020.12.028_bib3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","article-title":"Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer","volume":"36","author":"Overman","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2020.12.028_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/EJE-19-0238","article-title":"Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis","volume":"181","author":"Faje","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.crad.2020.12.028_bib5","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa046.1693","article-title":"SUN-127 diagnostic challenges associated with the rising incidence of endocrine toxicity in the era of combination immunotherapy","volume":"4","author":"Galligan","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.crad.2020.12.028_bib6","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2020.12.028_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40842-016-0034-8","article-title":"Hypophysitis: evaluation and management","volume":"2","author":"Faje","year":"2016","journal-title":"Clin Diabetes Endocrinol"},{"key":"10.1016\/j.crad.2020.12.028_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2004-0011","article-title":"Autoimmune hypophysitis","volume":"26","author":"Caturegli","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.crad.2020.12.028_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11102-015-0671-4","article-title":"Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights","volume":"19","author":"Faje","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.crad.2020.12.028_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejca.2019.06.020","article-title":"Machine learning defined diagnostic criteria for differentiating pituitary metastasis from autoimmune hypophysitis in patients undergoing immune checkpoint blockade therapy","volume":"119","author":"Mekki","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.crad.2020.12.028_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-14-0845","article-title":"Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma","volume":"172","author":"Albarel","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.crad.2020.12.028_bib12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1158\/1078-0432.CCR-14-2353","article-title":"Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study","volume":"21","author":"Min","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.crad.2020.12.028_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2265.1995.tb01881.x","article-title":"Lymphocytic adenohypophysitis: magnetic resonance imaging features of two new cases and a review of the literature","volume":"42","author":"Powrie","year":"1995","journal-title":"Clin Endocrinol"},{"issue":"Suppl. 1","key":"10.1016\/j.crad.2020.12.028_bib14","first-page":"OR32-6","article-title":"OR32-06 opportunistic assessment of pituitary gland with routine MRI and PET\/CT can guide in earlier and increased identification of hypophysitis in patients treated with combination checkpoint inhibitors","volume":"4","author":"Galligan","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.crad.2020.12.028_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11060-020-03396-w","article-title":"Current status and treatment modalities in metastases to the pituitary: a systematic review","volume":"146","author":"Ng","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.crad.2020.12.028_bib16","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.rcl.2020.07.009","article-title":"Neuroimaging of the pituitary gland: practical anatomy and pathology","volume":"58","author":"Chapman","year":"2020","journal-title":"Radiol Clin N Am"},{"key":"10.1016\/j.crad.2020.12.028_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11547-019-01120-x","article-title":"Imaging findings in hypophysitis: a review","volume":"125","author":"Caranci","year":"2020","journal-title":"Radiol Med"},{"key":"10.1016\/j.crad.2020.12.028_bib18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.crad.2014.07.010","article-title":"Benign and malignant diseases of the clivus","volume":"69","author":"Neelakantan","year":"2014","journal-title":"Clin Radiol"},{"issue":"12","key":"10.1016\/j.crad.2020.12.028_bib19","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1007\/s00259-020-04815-w","article-title":"FDG PET\/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment","volume":"47","author":"Iravani","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2020.12.028_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3904\/kjim.2013.28.1.81","article-title":"Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions","volume":"28","author":"Seok","year":"2013","journal-title":"Korean J Intern Med"},{"issue":"Suppl. 4","key":"10.1016\/j.crad.2020.12.028_bib21","doi-asserted-by":"crossref","first-page":"iv119","DOI":"10.1093\/annonc\/mdx225","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Haanen","year":"2017","journal-title":"Ann Oncol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:37:18Z","timestamp":1773113838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926021000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0009926021000623"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2020.12.028","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The imaging of immunotherapy-related hypophysitis and other pituitary lesions in oncology patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2020.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}